Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181bbc540
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2009
Authors
Publisher
Elsevier BV